Test BackgroundLp(a) is an independent risk factor for cardiovascular disease. Concentrations are genetically determined, with high concentrations being associated with the higher risk phenotype. Quantitation of Lp(a) is performed by immunoassay with a nephelometric rate detection.
Clinical Indications Measurement of Lp (a) should be considered in patients with a moderate or high risk of cardiovascular disease.
Sample Required Serum preferred (red top), heparin (green top) and EDTA (lavender top) acceptable
Sample Volume 1 mL
Turnaround Time 1 week